Benutzer: Gast  Login
Titel:

Keynote-365 cohort b: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)-pretreated patients (pts) with metastatic castrate resistant prostate cancer (mCRPC).

Dokumenttyp:
Meeting Abstract
Autor(en):
Massard, Christophe; Retz, Margitta; Hammerer, Peter; Quevedo, Fernando; Fong, Peter C. C.; Berry, William R.; Gurney, Howard; Piulats, Josep M.; Joshua, Anthony; Linch, Mark David; Kolinsky, Michael; Romano, Emanuela; Sridhar, Srikala S.; Conter, Henry Jacob; Augustin, Marinela; Wu, Haiyan; Schloss, Charles; Poehlein, Christian Heinrich; Yu, Evan Y.
Zeitschriftentitel:
J Clin Oncol
Jahr:
2019
Band / Volume:
37 Suppl S
Heft / Issue:
7
Volltext / DOI:
doi:10.1200/JCO.2019.37.7_suppl.170
Print-ISSN:
0732-183X
TUM Einrichtung:
Urologische Klinik und Poliklinik
 BibTeX